D
Context Therapeutics Inc. CNTX
$0.8595 -$0.0134-1.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 11.35% 6.14% -0.92% -4.52% -10.30%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 91.25% 42.29% 19.35% 47.79% 0.69%
Operating Income -91.25% -42.29% -19.35% -47.79% -0.69%
Income Before Tax -84.24% -29.60% -11.52% -45.30% 0.87%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -84.24% -29.60% -11.52% -45.30% 0.87%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -84.24% -29.60% -11.52% -45.30% 0.87%
EBIT -91.25% -42.29% -19.35% -47.79% -0.69%
EBITDA -91.28% -42.30% -19.36% -47.83% -0.70%
EPS Basic 62.50% 74.03% 64.79% 29.86% 9.43%
Normalized Basic EPS 62.48% 74.03% 64.79% 29.85% 9.41%
EPS Diluted 58.49% 70.84% 61.96% 29.86% 9.43%
Normalized Diluted EPS 62.48% 74.03% 64.79% 29.85% 9.41%
Average Basic Shares Outstanding 242.99% 389.41% 265.36% 162.07% 61.06%
Average Diluted Shares Outstanding 242.99% 389.41% 265.36% 162.07% 61.06%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --